Login
Hexo NYSE: HEXO
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market.
| Name | Hexo |
| Ticker | HEXO |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Finance |
| Price | 0.77 |
| 52W Low/High | 0.36 / 4.40 |
| Market cap | 199 M |
| 1Y Total Return |
-82.27%
Weak |
| 1Y Volatility |
149.72%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market.
Details
| Ticker | HEXO |
| Name | Hexo |
| ISIN | |
| CUSIP | |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Cannabis Finance |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 9/18/20
| Close Price | 0.77 |
| 52W Low/High | 0.36 / 4.40 |
| Market cap | 199 M |
| 1Y Total Return |
-82.27%
Weak |
| 1Y Volatility |
149.72%
High Risk |
| Beta | 0.14 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -146.4% |
| Cash from Op. / Cur. Liabilities | -2.37 |
| Diluted Earnings / Share | -0.25 |
| ROE | - |
| ROIC | -4.1% |
| Price / Revenue | 4.5 |
| Price / Book | 0.3 |
| Price / CF | -1.7 |
| Current Ratio | 5.9 |
| Cur.Liabilities / Tot.Liabilities | 0.6 |
| Financial Leverage | 0.04 |
| in Mils USD |
rolling-year up to June
|
||
|---|---|---|---|
| Income Statement | 2019 | 2018 | |
| Revenue |
36
|
4
|
|
| Gross Profit |
19
|
5
|
|
| R&D |
2
|
0
|
|
| EBITDA |
-64
|
-15
|
|
| Operating Income |
-66
|
-14
|
|
| Net Income exc. Extra |
-
|
-
|
|
| per Share | |||
| Diluted avg Shares |
213
|
134
|
|
| EPS exc. Extra |
-0.25
|
-0.13
|
|
| Dividend |
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
|
| Balance Sheet | 2019 | 2018 | |
| Total Assets |
671
|
254
|
|
| Cash, Eq & Invt ShortTerm |
134
|
193
|
|
| Total Current Assets |
238
|
210
|
|
| Total Non-Current Assets |
432
|
44
|
|
| Intangibles |
183
|
3
|
|
| Total Liabilities |
69
|
9
|
|
| Total Current Liabilities |
40
|
9
|
|
| Long Term Debt |
28
|
0
|
|
| Shareholder equity |
601
|
245
|
|
| Cash Flow | 2019 | 2018 | |
| Cash from Operations |
-95
|
-17
|
|
| Depreciation |
3
|
1
|
|
| Cash from Investing |
-6
|
-152
|
|
| Capex |
105
|
35
|
|
| Cash from Financing |
112
|
215
|
|
| Stock Issued |
47
|
114
|
|
| Debt (LT) Issued |
25
|
52
|
|
| Free Cash Flow |
-75
|
-
|
|
| Ratios | 2019 | 2018 | |
| Net Profit Margin |
-
|
-
|
|
| NCFO / Op.Income |
-
|
-
|
|
| Current Ratio |
5.9
|
22.8
|
|
| Financial Leverage D/E |
0.04
|
0.00
|
|
| Return on Capital Avg |
-4.1%
|
-19.5%
|
|
| Return on Shareholder Equity |
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available